CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale EVP, Chief Medical Officer sold 1,748 shares at $15.52 ($27,127)
- 4 Open-market sale EVP, Chief Dev. Officer sold 2,046 shares at $15.52 ($31,752)
- 4 Open-market sale SVP, CFO & Treasurer sold 2,858 shares at $15.52 ($44,354)
- 4 Open-market sale President & CSO sold 13,243 shares at $15.52 ($205,518)
- 4 Open-market sale Chief Executive Officer sold 13,243 shares at $15.52 ($205,518)
- 4 Exercise or conversion EVP, Chief Medical Officer acquired 5,650 shares (option exercise)
- 4 Exercise or conversion EVP, Chief Reg. Affairs acquired 5,650 shares (option exercise)
- 4 Exercise or conversion EVP, Chief Dev. Officer acquired 5,650 shares (option exercise)
- 4 Exercise or conversion SVP, CFO & Treasurer acquired 8,150 shares (option exercise)
- 4 Exercise or conversion President & CSO acquired 28,600 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 28,600 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 5,000 shares at $18.00 ($90,000)
- 4 Open-market sale Director sold 20,000 shares at an average $16.07 ($321,383)
- 4 Open-market sale EVP, CBO, GC & Secretary sold 137,061 shares at an average $17.53 ($2,402,227)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP,Chief Reg.&Quality Officer sold 226 shares at $15.58 ($3,521)
- 4 Open-market sale EVP, Chief Medical Officer sold 589 shares at $19.46 ($11,462)
Page 13 of 31 · 601 filings